Evidence map›Paper›PMID 35194049›Full record

ArticleNature communications2022

Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core.

Alexander J Pak, Alvin Yu, Zunlong Ke, John A G Briggs, Gregory A Voth

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Collective fluctuations underlying nanobody inhibitory activity targetingbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Making the cut: Multiscale simulation of membrane remodeling.Current opinion in structural biology · 2024
    Review
  17. Article
  18. Article
  19. HIV-1 capsid shape, orientation, and entropic elasticity regulate translocation into the nuclear pore complex.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Alexander J PakDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-2823-6480
Alvin YuDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-8051-7661
Zunlong KeStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0002-8408-850X
John A G BriggsStructural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0003-3990-6910
Gregory A VothDepartment of Chemistry, The University of Chicago, Chicago, IL, USA. gavoth@uchicago.edu.ORCID http://orcid.org/0000-0002-3267-6748
MRC Laboratory of Molecular Biology · GBUniversity of Chicago · USColorado School of Mines · US

Funding

Computational and Theoretical Studies of Retroviral Replication - ResubmissionF32AI150208 · NIAID · UNIVERSITY OF CHICAGO · PI YU, ALVIN · 2020 to 2022
$147k
Theory and SImulation of Viral ReplicationK99AI167034 · NIAID · UNIVERSITY OF CHICAGO · PI YU, ALVIN · 2022 to 2022
$90k
Computational Insights into Assembly, Budding, and Maturation during HIV-1 ReplicationF32AI150477 · NIAID · UNIVERSITY OF CHICAGO · PI PAK, ALEXANDER · 2019 to 2019
$64k
Medical Research Council MC_UP_1201/16NIAID NIH HHS F32 AI150208NIAID NIH HHS F32 AI150477NIAID NIH HHS K99 AI167034
6 · The paper itself

Abstract

The molecular events that permit the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to bind and enter cells are important to understand for both fundamental and therapeutic reasons. Spike proteins consist of S1 and S2 domains, which recognize angiotensin-converting enzyme 2 (ACE2) receptors and contain the viral fusion machinery, respectively. Ostensibly, the binding of spike trimers to ACE2 receptors promotes dissociation of the S1 domains and exposure of the fusion machinery, although the molecular details of this process have yet to be observed. We report the development of bottom-up coarse-grained (CG) models consistent with cryo-electron tomography data, and the use of CG molecular dynamics simulations to investigate viral binding and S2 core exposure. We show that spike trimers cooperatively bind to multiple ACE2 dimers at virion-cell interfaces in a manner distinct from binding between soluble proteins, which processively induces S1 dissociation. We also simulate possible variant behavior using perturbed CG models, and find that ACE2-induced S1 dissociation is primarily sensitive to conformational state populations and the extent of S1/S2 cleavage, rather than ACE2 binding affinity. These simulations reveal an important concerted interaction between spike trimers and ACE2 dimers that primes the virus for membrane fusion and entry.

Indexed as

AlgorithmsAngiotensin-Converting Enzyme 2COVID-19Host-Pathogen InteractionsHumansMembrane FusionMolecular Dynamics SimulationProtein BindingProtein DomainsProtein MultimerizationReceptors, VirusSARS-CoV-2Spike Glycoprotein, CoronavirusVirus AttachmentVirus InternalizationACE2 protein, humanAngiotensin-Converting Enzyme 2Receptors, VirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35194049
PMCPMC8863989
OpenAlexW4220804190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.